SCHEMBL6559952

SCHEMBL6559952

CCCCN(C1CC(C)(C)Oc2ccc(C(=O)OC)cc21)S(=O)(=O)CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HIF1A Q16665 1/20 0.36
EPAS1 Q99814 1/20 0.36
CNR2 P34972 4/20 0.35
CNR1 P21554 2/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KCNE1 P15382 2/20 0.35
KCNQ1 P51787 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
TSHR P16473 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
MGLL Q99685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559205 0.92 SMN1; SMN2 (0.38) KCNA5MEN1KMT2ACNR2LMNA
SCHEMBL7830067 0.91 KCNE1 (0.37) KCNA5MEN1KMT2ACNR2CNR1
SCHEMBL6559927 0.89 KCNA5 (0.41) KCNA5MEN1KMT2AHIF1AEPAS1
SCHEMBL6559386 0.88 KCNA5 (0.39) KCNA5MEN1KMT2AHIF1AEPAS1
SCHEMBL6558710 0.87 KCNA5 (0.35) KCNA5MEN1KMT2ACNR2CNR1
SCHEMBL6560813 0.86 KCNE1 (0.42) KCNA5MEN1KMT2ACNR2LMNA
SCHEMBL6559333 0.85 KCNE1 (0.44) KCNA5L3MBTL1MEN1KMT2ACNR2
SCHEMBL6559403 0.84 KCNA5 (0.37) KCNA5MEN1KMT2ALMNAALDH1A1
SCHEMBL6559604 0.83 MEN1 (0.36) KCNA5MEN1KMT2ACNR2LMNA
SCHEMBL6558722 0.81 KCNE1 (0.48) HIF1AEPAS1KCNE1KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed